Special Issues in the Diagnosis and Treatment of ADHD in Adolescents

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Postgraduate medicine

• Publication date

  2008-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3810/pgm.2008.09.1908PMID 18824826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attention deficit hyperactivity disorder.

  2018cited by this paper
• Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.

  2007cited by this paper
• Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit / Hyperactivity Disorder

  2007cited by this paper
• The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

  2006cited by this paper
• Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study

  2006cited by this paper
• Relative Benefits of Stimulant Therapy With OROS Methylphenidate Versus Mixed Amphetamine Salts Extended Release in Improving the Driving Performance of Adolescent Drivers With Attention-Deficit/Hyperactivity Disorder

  2006cited by this paper
• Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents.

  2006cited by this paper
• Once-Daily OROS® Methylphenidate Is Safe and Well Tolerated in Adolescents With Attention-Deficit/Hyperactivity Disorder

  2006cited by this paper
• Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.

  2006cited by this paper
• Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.

  2006cited by this paper
• Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth

  2006cited by this paper
• Attention-Deficit/Hyperactivity Disorder Among Adolescents: A Review of the Diagnosis, Treatment, and Clinical Implications

  2005cited by this paper
• AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

  2005cited by this paper
• The effect of ADHD on the life of an individual, their family, and community from preschool to adult life

  2005cited by this paper
• Clinical practice. Attention deficit-hyperactivity disorder.

  2005cited by this paper
• Attention-deficit hyperactivity disorder

  2005cited by this paper
• Abuse-resistant drug delivery.

  2005cited by this paper
• The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

  2005cited by this paper
• Attention-deficit/hyperactivity disorder and early-onset substance use disorders.

  2005cited by this paper
• Psychostimulant Treatment and Risk for Substance Abuse Among Young Adults with a History of Attention-Deficit/Hyperactivity Disorder: APopulation-Based, Birth Cohort Study

  2005cited by this paper
• Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

  2004cited by this paper
• Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder.

  2004cited by this paper
• Quality of life of adolescent males with Attention-Deficit Hyperactivity Disorder

  2004cited by this paper
• Psychiatric Comorbidities in Children with Attention Deficit Hyperactivity Disorder

  2003cited by this paper
• Long-Term Use of Stimulants in Children with Attention Deficit Hyperactivity Disorder

  2003cited by this paper
• Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.

  2003cited by this paper
• Does stimulant therapy of attention‐deficit/hyperactivity disorder beget later substance abuse?

  2003cited by this paper
• Defining clinical phenotypes of juvenile mania.

  2003cited by this paper
• Does stimulant treatment lead to substance use disorders?

  2003cited by this paper
• Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.

  2003cited by this paper
• Aspects of social and emotional competence in adult attention-deficit/hyperactivity disorder.

  2003cited by this paper
• Mental health of children and adolescents in Great Britain

  2003cited by this paper
• Correlates of comorbid psychopathology in children with ADHD.

  2003cited by this paper
• Young Adult Follow-Up of Hyperactive Children: Self-Reported Psychiatric Disorders, Comorbidity, and the Role of Childhood Conduct Problems and Teen CD

  2002cited by this paper
• Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.

  2001cited by this paper
• Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.

  2001cited by this paper
• Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

  2001cited by this paper
• Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.

  2000cited by this paper
• Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

  2000cited by this paper
• Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial.

  2000cited by this paper
• Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics.

  2000cited by this paper
• The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder.

  2000cited by this paper
• Stimulant medications : Current knowledge and unmet needs in pediatrics psychopharmacology

  1999cited by this paper
• Stimulant medications.

  1999cited by this paper
• Do Stimulants Improve Self-Esteem in Children with ADHD and Peer Problems?

  1999cited by this paper
• AOD Use and Attention Deficit/Hyperactivity Disorder

  1998cited by this paper
• Revision and Restandardization of the Conners Teacher Rating Scale (CTRS-R): Factor Structure, Reliability, and Criterion Validity

  1998cited by this paper
• Puberty and depression: the roles of age, pubertal status and pubertal timing

  1998cited by this paper
• Prospective Study of Tobacco Smoking and Substance Dependencies Among Samples of ADHD and Non-ADHD Participants

  1998cited by this paper
• The Revised Conners' Parent Rating Scale (CPRS-R): Factor Structure, Reliability, and Criterion Validity

  1998cited by this paper
• ADHD is associated with early initiation of cigarette smoking in children and adolescents.

  1997cited by this paper
• Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.

  1997cited by this paper
• Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials.

  1997cited by this paper
• Childhood and adolescent depression: a review of the past 10 years. Part I.

  1996cited by this paper
• Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds.

  1993cited by this paper
• Adolescents with ADHD: patterns of behavioral adjustment, academic functioning, and treatment utilization.

  1991cited by this paper
• Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders.

  1991cited by this paper
• Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height.

  1988cited by this paper
• Followup studies on outcome of hyperactive children.

  1985cited by this paper
• Hyperactive boys almost grown up. I. Psychiatric status.

  1985cited by this paper
• Studies on the Hyperactive Child: VIII. Five-Year Follow-up

  1971cited by this paper
• Studies on the hyperactive child. 8. Five-year follow-up.

  1971cited by this paper
• THE PEDIATRICIAN AND THE PUBLIC NATIONAL HEALTH SERVICE OF GREAT BRITAIN

  1953cited by this paper

• Wearable Signals for Diagnosing Attention-Deficit/Hyperactivity Disorder in Adolescents: A Feasibility Study

  2024cites this paper
• Relevance of ω-6 GLA Added to ω-3 PUFAs Supplements for ADHD: A Narrative Review

  2022cites this paper
• Life Persistence of Attention-Deficit/Hyperactivity Disorder

  2016cites this paper
• Clinical Practice Guidelines for Major Comorbid Disorders with Attention-Deficit Hyperactivity Disorder

  2016cites this paper
• Prefrontal cortical α2A-adrenoceptors and a possible primate model of attention deficit and hyperactivity disorder

  2015cites this paper
• Diagnosis of children's attention deficit hyperactivity disorder (ADHD) and its association with cytomegalovirus infection with ADHD: a historical review.

  2015cites this paper
• Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum

  2014cites this paper
• CLINICAL IMPLICATIONS OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) ON ADOLESCENCE: REVIEW

  2014cites this paper
• Challenges in the Transition of Care for Adolescents With Attention-Deficit/Hyperactivity Disorder

  2013cites this paper
• Naturalistic exploration of the effect of osmotic release oral system‐methylphenidate on remission rate and functional improvement in Taiwanese children with attention‐deficit–hyperactivity disorder

  2012cites this paper
• Discontinuity in the Transition from Pediatric to Adult Health Care for Patients with Attention–Deficit/Hyperactivity Disorder

  2012cites this paper
• Cocaine responsiveness or anhedonia in rats treated with methylphenidate during adolescence.

  2010cites this paper
• Review of Attention-Deficit/Hyperactivity Disorder Comorbid with Oppositional Defiant Disorder

  2010cites this paper
• A 6-Month, Open-Label, Extension Study of the Tolerability and Effectiveness of the Methylphenidate Transdermal System in Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder

  2010cites this paper
• Mouth breathing: adverse effects on facial growth, health, academics, and behavior.

  2010cites this paper
• Correlation between methylphenidate and ritalinic acid concentrations in oral fluid and plasma.

  2010cites this paper
• An Update on Central Nervous System Stimulant Formulations in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

  2009cites this paper
• In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.

  2009cites this paper
• Attention-Deficit/Hyperactivity Disorder: Review Questions

  2009cites this paper
• Extended release stimulant medication misuse with alcohol co-administration.

  2008cites this paper